Cullin-3 and Regulatory Biomolecules Profiling in Vitiligo: Integrated Docking, Clinical, and In Silico Insights
Biomolecules · 2025
DOI: 10.3390/biom15071053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Hidi A A Abdellatif und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt. Hauptthemen laut MEDLINE: Vitiligo, Cullin Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Border University, Saudi Arabia.
Abstract (Originalsprache)
Background
Vitiligo, a chronic depigmentation disorder driven by oxidative stress and immune dysregulation, remains poorly understood mechanistically. The Keap1/NRF2/ARE pathway is critical for melanocyte protection against oxidative damage; however, the role of Cullin-3 (CUL3), a scaffold for E3 ubiquitin ligases that regulate NRF2 degradation, and its interplay with inflammatory mediators in vitiligo pathogenesis are underexplored. This study investigates CUL3, NRF2, and the associated regulatory networks in vitiligo, integrating clinical profiling and computational docking to identify therapeutic targets.
Methods
A case-control study compared non-segmental vitiligo patients with age-/sex-matched controls. Lesional skin biopsies were analyzed by qRT-PCR for the expression of CUL3, NRF2, miRNA-146a, FOXP3, NF-κB, IL-6, TNF-α, and P53. Molecular docking was used to evaluate vitexin’s binding affinity to Keap1, validated by root mean square deviation (RMSD) calculations.
Results
Patients with vitiligo exhibited significant downregulation of CUL3 (0.27 ± 0.03 vs. 1 ± 0.58; p = 0.013), NRF2 (0.37 ± 0.26 vs. 1 ± 0.8; p = 0.001), and FOXP3 (0.09 ± 0.2 vs. 1 ± 0.3; p = 0.001), alongside the upregulation of miRNA-146a (4.7 ± 1.9 vs. 1 ± 0.8; p = 0.001), NF-κB (4.7 ± 1.9 vs. 1 ± 0.5; p = 0.001), IL-6 (2.8 ± 1.5 vs. 1 ± 0.4; p = 0.001), and TNF-α (2.2 ± 1.1 vs. 1 ± 0.3; p = 0.001). P53 showed no differential expression (p > 0.05). Docking revealed a strong binding of vitexin to Keap1 (RMSD: 0.23 Å), mirroring the binding of the control ligand CDDO-Im.
Conclusions
Dysregulation of the CUL3/Keap1/NRF2 axis and elevated miRNA-146a levels correlate with vitiligo progression, suggesting a role for oxidative stress and immune imbalance. Vitexin’s high-affinity docking to Keap1 positions it as a potential modulator of the NRF2 pathway, offering novel therapeutic avenues. This study highlights the translational potential of targeting the ubiquitin–proteasome and antioxidant pathways in the management of vitiligo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
- Oncology Diagnostic Unit, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
- Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, King Salman International University, Tur Sinai 46618, Egypt.
- Dermatology, Venereology and Andrology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
- Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
- Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.
ORCID-Profile: Hidi A A Abdellatif, Dhaifallah A Alenizi, Manal S Fawzy, Noha M Abd El-Fadeal
Förderung
- Northern Border University, Saudi Arabia
Zitieren
APA
Abdellatif, H. A. A., Azab, M., El-Sayed, E. H., Halim, R. M. M. M., Milebary, A. J., Alenizi, D. A., Fawzy, M. S., & Abd El-Fadeal, N. M. (2025). Cullin-3 and Regulatory Biomolecules Profiling in Vitiligo: Integrated Docking, Clinical, and In Silico Insights. Biomolecules. https://doi.org/10.3390/biom15071053
Vancouver
Abdellatif HAA, Azab M, El-Sayed EH, Halim RMMM, Milebary AJ, Alenizi DA, et al. Cullin-3 and Regulatory Biomolecules Profiling in Vitiligo: Integrated Docking, Clinical, and In Silico Insights. Biomolecules. 2025. doi:10.3390/biom15071053
BibTeX
@article{Abdellatif2025,
author = {Abdellatif, Hidi A A and Azab, Mohamed and El-Sayed, Eman Hassan and Halim, Rwan M M M and Milebary, Ahmad J and Alenizi, Dhaifallah A and Fawzy, Manal S and Abd El-Fadeal, Noha M},
title = {Cullin-3 and Regulatory Biomolecules Profiling in Vitiligo: Integrated Docking, Clinical, and In Silico Insights},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15071053}
}
EUVIMED